AI models fast‑track drug discovery and protein structure prediction

Artificial‑intelligence algorithms that analyse massive biological data sets can now anticipate how cells will respond to drug candidates, dramatically shortening the traditional decade‑long, multi‑hundred‑million‑dollar discovery process. By integrating genetic sequences, microscope images, protein‑expression profiles and metabolic information, these predictive laboratory models generate virtual cells that help researchers pinpoint promising molecules and flag possible side‑effects early in development.

Recent generative‑AI systems such as DeepMind’s AlphaFold and the newer ESMFold2 can predict three‑dimensional protein structures in seconds and even design novel proteins. Real‑time structural predictions accelerate biomedical research, supporting faster creation of therapies and biotechnological applications.